BIOS News and Press, BioPlus Acquisition Corp. From 03/18/19

NEW YORK, NY / ACCESSWIRE / March 18, 2019 / Traders News Source, a leading independent equity researchand corporate access firm focused on small and mid-cap public companies isissuing a comprehensive report on BioScrip Inc. (NASDAQ: BIOS) , a provider of infusion and home care management s...

BioScrip, Inc. (BIOS) Q4 2018 Results and BioScrip, and Option Care Merger Transaction Conference Call March 15, 2019 09:00 AM ET Company Participants Kathryn Stalmack - SVP and General Counsel Dan Greenleaf - President and CEO Steve Deitsch - SVP, CFO and Treasurer John Radema...

Gainers:  Soleno Therapeutics (NASDAQ: SLNO ) +210% . Achieve Life Sciences (NASDAQ: ACHV ) +33% . Catasys (NASDAQ: CATS ) +26% . Prana Biotechnology (NASDAQ: PRAN ) +24% . Avid Technology (NASDAQ: AVID ) +23% . Magenta Therapeutics (NASDAQ: MGTA ) +22% . Leap Therapeutics (NASD...

The following slide deck was published by BioScrip, Inc. in conjunction with their 2018 Q4 earnings Read more ...

Achieve Life Sciences (NASDAQ: ACHV ) +77%  on advancement of cytisinicline. More news on: Achieve Life Sciences, Inc., Soleno Therapeutics, Inc., MDC Partners Inc., Stocks on the move, Read more ...

Biocrip (NASDAQ: BIOS ) and home infusion services provider  Option Care Enterprises have agreed to merge in an all-stock transaction. Under the terms of the deal, BIOS will issue new shares to Option Care's shareholder, owned by funds affiliated with Madison Dearborn Partners, LLC a...

BioScrip (NASDAQ: BIOS ): Q4 GAAP EPS of -$0.18 misses by $0.15 . More news on: BioScrip, Inc., Earnings news and commentary, Consumer stocks news, Read more ...

DENVER, March 15, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced its fourth quarter and full year 2018 financial results.      ...

Creates a Leading Independent Provider of Home and Alternate Site Infusion Services with  Deep Clinical Expertise and Broad Therapy Portfolio Enhanced Scale and Improved Financial Profile Expected to Enable Growth in Attractive and Growing Segment of U.S. Healthcare Market ...

BIOS , BKE , DPLO , KIRK For Seeking Alpha's full earnings season calendar,  click here . More news on: BioScrip, Inc., The Buckle, Inc., Diplomat Pharmacy, Inc., Earnings news and commentary,